Related Experiment Video
Updated: Aug 18, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
[Invasive fungal infections in patients after liver transplantation]
1Klinik für hepatobiliäre Chirurgie und viszerale Transplantation, Universitätsklinikum Hamburg Eppendorf, D-20246 Hamburg, Germany. lfischer@uke.uni-hamburg.de
Abstract:
Advances in surgical technique, immunosuppression, and medical management have greatly improved clinical results after liver transplantation (LTx). Fungal infections in LTx-patients still represent serious complications and are associated with a significant decrease in survival. The majority of fungal infections in LTx-patients are caused by Candida species, which is explained by the major abdominal surgery. Aspergillus infections are second common, whereas other fungal infections such as pneumocystosis, cryptococcosis, or zygomycosis represent rare events. The high mortality of invasive fungal infections in LTx-recipients is explained by the severity of the underlying medical condition and by difficulties in diagnosis and medical therapy. Currently available diagnostic tests do not allow a timely and reliable diagnosis of invasive fungal infections in LTx-patients. Amphotericin B has been the standard treatment for invasive candidiasis and aspergillosis for many years but the high frequency of side effects limits its application. Fluconazole is widely used due to better tolerability and fewer drug interactions. Disadvantages are the lack of activity against Aspergillus species and the selection of resistant Candida strains. Progress is to be expected from new antimycotic agents belonging to azoles (voriconazole) and echinocandins (caspofungin) as these are less toxic and have a broad range of antimycotic activity. Analysis of prognostic factors allows identifying LTx-patients at high risk for invasive fungal infection. Antimycotic prophylaxis or pre-emptive therapy may improve clinical outcome in this patient subgroup.
Insights
Fungal infections pose a significant threat to liver transplant (LTx) recipients, decreasing survival rates. Early identification and new antifungal treatments are crucial for improving outcomes in these high-risk patients.
Area of Science:
- Medical Mycology
- Transplantation Surgery
- Infectious Diseases
Background:
- Liver transplantation (LTx) outcomes have improved, but fungal infections remain a major complication.
- Fungal infections, primarily Candida and Aspergillus, significantly reduce survival in LTx patients.
- Current diagnostics and therapies for invasive fungal infections in LTx recipients are limited.
Purpose of the Study:
- To review the challenges and advancements in managing fungal infections after liver transplantation.
- To highlight the impact of fungal infections on LTx patient survival and treatment efficacy.
- To discuss current and emerging diagnostic and therapeutic strategies for invasive fungal infections in LTx.
Main Methods:
- Literature review of fungal infections in liver transplant patients.
- Analysis of current diagnostic methods and their limitations.
- Evaluation of existing and novel antifungal agents and treatment strategies.
Main Results:
- Candida species are the most common fungal pathogens in LTx patients, followed by Aspergillus.
- High mortality associated with invasive fungal infections is linked to patient condition and diagnostic/therapeutic challenges.
- Newer antifungals like voriconazole and caspofungin offer broader activity and better tolerability than older agents.
- Prognostic factor analysis can identify high-risk LTx patients for targeted interventions.
Conclusions:
- Invasive fungal infections remain a critical challenge in liver transplantation, impacting patient survival.
- Timely diagnosis and effective treatment, including prophylaxis and pre-emptive therapy, are essential for improving outcomes.
- Advancements in antifungal agents offer improved safety and efficacy for managing these infections.
Related Concept Videos
Cryptococcal Meningitis
Kidney Transplant III: Nursing Management
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant II: Surgical Procedure
Fungal Phylum Microsporidia
Candidiasis
